Liliana Faviola de la Cerda-Trujillo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liliana Faviola de la Cerda-Trujillo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Alfredo Celis
Division of Disciplines for the Development, Promotion and Preservation of Health, CUCS, U de G, Guadalajara, Jalisco, Mexico
1 shared publication- Ana Miriam Saldaña-Cruz
Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico
1 shared publication C. R. Lopez‐Lizárraga
Division of Surgery Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Guadalajara Mexico
1 shared publicationCarlos Gutiérrez-Chávez
Department of General Surgery, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Mexico
1 shared publicationCarlos Rene López-Lizarraga
Department of Surgery, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Mexico
1 shared publication- César Felipe Ploneda-Valencia
Department of General Surgery, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Mexico
1 shared publication
Latest Publications
- 12 March 2020
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 33 (3) , 299-307
Physical inactivity and excessive sucrose consumption are associated with higher serum lipids in subjects with Taq1B CETP polymorphism
Background: Dyslipidaemias result from the interaction between genetic and environmental factors, including diet disequilibrium and physical inactivity. Among the genetic factors associated with serum lipids, the Taq1B CETP polymorphism has been investigated. The B1 allele has been considered as a risk factor for dyslipidaemia because of its association with greater CETP levels and higher serum triglycerides. The present study aimed to determine the role of the Taq1B polymorphism with lipid and anthropometric variables and its interaction with diet and physical activity.Methods: In total, 215 subjects were enrolled in this cross‐sectional study. Diet intake was evaluated using a 3‐day food consumption record and physical activity was determined in accordance with World Health Organization recommendations. The Taq1B CETP polymorphism was determined by allelic discrimination.Results: Subjects with the B1B2/B2B2 genotype, who had a sucrose consumption ≥5% of the total kcal day−1, had higher levels of total cholesterol (TC) [165.55 (142.21–188.89) mg dL−1 versus 200.19 (184.79–215.60) mg dL−1; P for interaction = 0.034] and low‐density lipoprotein [99.29 (75.52–123.05) mg dL−1 versus 128.64 (113.59–143.69) mg dL−1; P for interaction = 0.037] than subjects with the B1B1 genotype. Subjects who did not perform physical activity and had the B1B2/B2B2 genotype showed significantly higher levels of TC [177.48 (161.36–193.60) mg dL−1 versus 194.49 (185.43–203.56) mg mL−1; P for interaction = 0.033] than subjects with the B1B1 genotype.Conclusions: We provide evidence that subjects with inadequate environmental factors carriers of the polymorphic genotype had higher serum lipid levels than subjects with the B1B1 genotype.
- 12 March 2020
- Published by Wiley in Journal of Human Nutrition and Dietetics
- Vol. 33 (3) , 299-307
Physical inactivity and excessive sucrose consumption are associated with higher serum lipids in subjects with Taq1B CETP polymorphism
Background: Dyslipidaemias result from the interaction between genetic and environmental factors, including diet disequilibrium and physical inactivity. Among the genetic factors associated with serum lipids, the Taq1B CETP polymorphism has been investigated. The B1 allele has been considered as a risk factor for dyslipidaemia because of its association with greater CETP levels and higher serum triglycerides. The present study aimed to determine the role of the Taq1B polymorphism with lipid and anthropometric variables and its interaction with diet and physical activity.Methods: In total, 215 subjects were enrolled in this cross‐sectional study. Diet intake was evaluated using a 3‐day food consumption record and physical activity was determined in accordance with World Health Organization recommendations. The Taq1B CETP polymorphism was determined by allelic discrimination.Results: Subjects with the B1B2/B2B2 genotype, who had a sucrose consumption ≥5% of the total kcal day−1, had higher levels of total cholesterol (TC) [165.55 (142.21–188.89) mg dL−1 versus 200.19 (184.79–215.60) mg dL−1; P for interaction = 0.034] and low‐density lipoprotein [99.29 (75.52–123.05) mg dL−1 versus 128.64 (113.59–143.69) mg dL−1; P for interaction = 0.037] than subjects with the B1B1 genotype. Subjects who did not perform physical activity and had the B1B2/B2B2 genotype showed significantly higher levels of TC [177.48 (161.36–193.60) mg dL−1 versus 194.49 (185.43–203.56) mg mL−1; P for interaction = 0.033] than subjects with the B1B1 genotype.Conclusions: We provide evidence that subjects with inadequate environmental factors carriers of the polymorphic genotype had higher serum lipid levels than subjects with the B1B1 genotype.
- 1 October 2017
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 23 (7) , 376-382
Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs
Background: There is limited information about the factors related with the development of long-term permanent work disability (PWD) in rheumatoid arthritis (RA) treated with a combination of conventional synthetic disease-modifying antirheumatic drugs (cs-DMARDs). Objective: The aim of this study was to evaluate incidence and factors associated with the development of PWD in RA treated with combination therapy using conventional synthetic cs-DMARDs. Methods: We assessed in multivariate models the effect of clinical and demographic factors in the development of PWD in a long-term retrospective cohort of 180 workers with RA who were treated with a combination of cs-DMARDs. Results: Incidence rates of PWD were 2.2% at 1 year, 7.7% at 5 years, 24.9% at 10 years, 34.9% at 15 years, and 45% at 20 years. In the adjusted Cox regression analysis, factors associated with PWD development were the first failure with combination of cs-DMARDs (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.05–5.46; P = 0.03), poor functioning at time of cohort onset (HR, 2.2; 95% CI, 1.05–4.70; P = 0.03), and requirement for joint replacement (HR, 3.3; 95% CI, 1.28–8.79; P = 0.01). Conclusions: Around 25% of workers with combination therapy with cs-DMARDs developed PWD in 10 years following the diagnosis of RA. Some factors increase the risk of disability. Permanent work disability generates a relevant society burden and increases health care costs. Therefore, indicators predicting failure of combination therapies with cs-DMARDs might provide clinicians of useful tools for modifying treatments avoiding the disease progression.
- 1 October 2017
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 23 (7) , 376-382
Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs
Background: There is limited information about the factors related with the development of long-term permanent work disability (PWD) in rheumatoid arthritis (RA) treated with a combination of conventional synthetic disease-modifying antirheumatic drugs (cs-DMARDs). Objective: The aim of this study was to evaluate incidence and factors associated with the development of PWD in RA treated with combination therapy using conventional synthetic cs-DMARDs. Methods: We assessed in multivariate models the effect of clinical and demographic factors in the development of PWD in a long-term retrospective cohort of 180 workers with RA who were treated with a combination of cs-DMARDs. Results: Incidence rates of PWD were 2.2% at 1 year, 7.7% at 5 years, 24.9% at 10 years, 34.9% at 15 years, and 45% at 20 years. In the adjusted Cox regression analysis, factors associated with PWD development were the first failure with combination of cs-DMARDs (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.05–5.46; P = 0.03), poor functioning at time of cohort onset (HR, 2.2; 95% CI, 1.05–4.70; P = 0.03), and requirement for joint replacement (HR, 3.3; 95% CI, 1.28–8.79; P = 0.01). Conclusions: Around 25% of workers with combination therapy with cs-DMARDs developed PWD in 10 years following the diagnosis of RA. Some factors increase the risk of disability. Permanent work disability generates a relevant society burden and increases health care costs. Therefore, indicators predicting failure of combination therapies with cs-DMARDs might provide clinicians of useful tools for modifying treatments avoiding the disease progression.
- 14 June 2016
- Published by Elsevier in International Journal of Surgery
- Vol. 32, 6-9
Acute appendicitis in an overweight and obese Mexican population: A retrospective cohort study
- 14 June 2016
- Published by Elsevier in International Journal of Surgery
- Vol. 32, 6-9
Acute appendicitis in an overweight and obese Mexican population: A retrospective cohort study